SCHEMBL13487668

SCHEMBL13487668

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4cnc5ccccc5n4)c4ccc(-c5ccc6ccccc6c5)cc34)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.36
MAPT P10636 4/20 0.34
KDM4E B2RXH2 2/20 0.34
MET P08581 1/20 0.34
RAB9A P51151 7/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HPGD P15428 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BCHE P06276 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK10 P53779 1/20 0.32
ATM Q13315 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
PIK3CD O00329 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488059 0.95 NPC1 (0.36) NPC1MAPTKDM4EMETRAB9A
SCHEMBL13487773 0.93 NPC1 (0.38) NPC1MAPTKDM4ERAB9AALDH1A1
SCHEMBL13487519 0.92 NPC1 (0.37) NPC1MAPTKDM4ERAB9AALDH1A1
SCHEMBL13487607 0.90 NPC1 (0.36) NPC1MAPTKDM4EMETRAB9A
SCHEMBL13488135 0.90 NPC1 (0.40) NPC1MAPTKDM4ERAB9AALDH1A1
SCHEMBL13487661 0.89 NPC1 (0.36) NPC1MAPTKDM4ERAB9AALDH1A1
SCHEMBL13487287 0.88 MET (0.36) NPC1MAPTKDM4EMETRAB9A
SCHEMBL13487452 0.88 NPC1 (0.39) NPC1MAPTKDM4ERAB9AALDH1A1
SCHEMBL13487669 0.87 ACACA (0.41) NPC1MAPTKDM4ERAB9AALDH1A1
SCHEMBL13487905 0.87 NPC1 (0.38) NPC1MAPTKDM4ERAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 NPC1 1139/4885MAPT 2219/4885KDM4E 3671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.